Critically, the intrinsic ability of iNKT cells to recognize CD1d-presented endogenous tumor lipids via their invariant TCR creates a dual-targeting synergy: this not only amplifies CAR-mediated cytotoxicity but also mitigates antigen escape by engaging lipid-specific killing pathways (77). Here, CD1D is linked to neoplasm.